D 10 (Didanosine delayed release 250 mg)
This pill with imprint "D 10" is White, Capsule-shape and has been identified as Didanosine delayed release 250 mg. It is supplied by Aurobindo Pharma.
Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
Didanosine delayed release
- Imprint:
- D 10
- Strength:
- 250 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Aurobindo Pharma
- Inactive Ingredients:
- sodium starch glycolate type A potato
carboxymethylcellulose sodium
sodium lauryl sulfate
hypromellose 2910 (3 mPa.s)
magnesium silicate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
diethyl phthalate
silicon dioxide
gelatin
titanium dioxide
ferrosoferric oxide
shellac
Note: Inactive ingredients may vary.
More about didanosine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Didanosine Delayed-Release Enteric-Coated Capsules
- Didanosine Oral Solution
- Didanosine
- Didanosine (Advanced Reading)
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
